TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Benchmarking
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Primary Health Care
KW - Access to health care
KW - buprenorphine
KW - Extensions for Community Healthcare Outcomes (ECHO)
KW - Internet-Based Intervention
KW - Medication-Assisted Treatment of Opioid
KW - opioid-related disorders
KW - Opioids
AU - A. L. Sussman
AU - J. N. Crawford
AU - H. R. Brakey
AU - R. S. Alkhafaji
AU - O. B. Myers
AU - V. Jacobsohn
AU - S. Bhatt
AU - J. Salvador
A1 - 
AD - From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS). asussman@salud.unm.edu.; From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).; From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sci(TRUNCATED)
BT - Journal of the American Board of Family Medicine : JABFM
C5 - Education & Workforce; Opioids & Substance Use
CP - 6
CY - United States
DO - 10.3122/jabfm.2021.06.210111
IS - 6
JF - Journal of the American Board of Family Medicine : JABFM
LA - eng
M1 - Journal Article
PB - by the American Board of Family Medicine
PP - United States
PY - 2021
SN - 1558-7118; 1557-2625
SP - 1216
EP - 1220
EP - 
T1 - Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
T2 - Journal of the American Board of Family Medicine : JABFM
TI - Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34772777
U3 - 10.3122/jabfm.2021.06.210111
VL - 34
VO - 1558-7118; 1557-2625
Y1 - 2021
Y2 - Nov-Dec
ER -